| Product NDC: | 76189-535 |
| Proprietary Name: | Iclusig |
| Non Proprietary Name: | ponatinib hydrochloride |
| Active Ingredient(s): | 15 mg/1 & nbsp; ponatinib hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 76189-535 |
| Labeler Name: | ARIAD Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203469 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121214 |
| Package NDC: | 76189-535-60 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (76189-535-60) |
| NDC Code | 76189-535-60 |
| Proprietary Name | Iclusig |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (76189-535-60) |
| Product NDC | 76189-535 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ponatinib hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20121214 |
| Marketing Category Name | NDA |
| Labeler Name | ARIAD Pharmaceuticals, Inc. |
| Substance Name | PONATINIB HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |